Multicentric Castleman Disease
4 clinical trials · Condition
◉ Watch Multicentric Castleman Disease
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi (NCT04585893) | UNC Lineberger Comprehensive Cancer Center | 2021-06-22 |
| TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial (NCT03043105) | Peking Union Medical College Hospital | 2017-01-01 |
| Tocilizumab for KSHV-Associated Multicentric Castleman Disease (NCT01441063) | National Cancer Institute (NCI) | 2011-09-13 |
Track Multicentric Castleman Disease automatically
Every clearance here is in the API, with alerts when new ones post.